摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(3-hydroxy-4-methoxybenzyl)-6-methoxy-3,4-dihydroisoquinoline | 95427-40-0

中文名称
——
中文别名
——
英文名称
1-(3-hydroxy-4-methoxybenzyl)-6-methoxy-3,4-dihydroisoquinoline
英文别名
1-(3-Hydroxy-4-methoxy-benzyl)-6-methoxy-3,4-dihydro-isochinolin;2-Methoxy-5-[(6-methoxy-3,4-dihydroisoquinolin-1-yl)methyl]phenol
1-(3-hydroxy-4-methoxybenzyl)-6-methoxy-3,4-dihydroisoquinoline化学式
CAS
95427-40-0
化学式
C18H19NO3
mdl
——
分子量
297.354
InChiKey
HBWVFVRHQGVHSP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.8
  • 重原子数:
    22
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.28
  • 拓扑面积:
    51
  • 氢给体数:
    1
  • 氢受体数:
    4

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    General asymmetric synthesis of isoquinoline alkaloids. Enantioselective hydrogenation of enamides catalyzed by BINAP-ruthenium(II) complexes
    摘要:
    In the presence of a small amount of RuX(2)[(R)- or (S)-BINAP] (X = anionic ligand) a wide range of (Z)-2-acyl-1-benzylidene-1,2,3,4-tetrahydroisoquinolines are hydrogenated to give the saturated products in nearly quantitative yields and in high (up to 100 %) optical yields. The enamide substrates are selectively prepared by N-acylation of the corresponding 1-benzylated 3,4-dihydroisoquinolines under suitable acylation conditions; some crystalline materials having low solubility are obtained by a second-order Z/E stereomutation technique utilizing the double-bond photolability and lattice energy effects. This asymmetric hydrogenation sets the key stereogenic center in a predictable manner, either R or S flexibly, at the C(1) position of the benzylated tetrahydroisoquinolines. The chiral products are converted by standard functional group modification to tetrahydropapaverine, laudanosine, tretoquinol, norreticuline, etc. Hydrogenation of the simple 1-methylene substrate is used fbr synthesis of salsolidine. This enantioselective hydrogenation is applied to the synthesis of morphine and its artificial analogues such as morphinans and benzomorphans of either chirality. A mnemonic device is presented for predicting the reactivity and enantiofacial selection of the BINAP-Ru catalyzed hydrogenation. Reaction with BINAP-Rh catalyst proceeds with a lower enantioselectivity and an opposite sense of asymmetric induction.
    DOI:
    10.1021/jo00081a007
  • 作为产物:
    描述:
    N-<2-(3-methoxyphenyl)ethyl>(3-hydroxy-4-methoxyphenyl)acetamide三氯氧磷 作用下, 以 乙腈 为溶剂, 反应 1.0h, 以0.427 g的产率得到1-(3-hydroxy-4-methoxybenzyl)-6-methoxy-3,4-dihydroisoquinoline
    参考文献:
    名称:
    Meuzelaar, Gerrit J.; Van Vliet, Michiel C. A.; Maat, Leendert, European Journal of Organic Chemistry, 1999, # 9, p. 2315 - 2321
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Substituted Berbines and Processes for their Synthesis
    申请人:Wang Peter X.
    公开号:US20100056789A1
    公开(公告)日:2010-03-04
    The present invention provides processes for the synthesis of substituted berbine compounds. Also provided are intermediates used in the synthesis of substituted berbine compounds.
    本发明提供了合成取代苯并喹啉化合物的方法。还提供了在合成取代苯并喹啉化合物中使用的中间体。
  • One-Pot Preparation of Hexahydroisoquinolines from Dihydroisoquinolines
    申请人:Grote Christopher W.
    公开号:US20110071300A1
    公开(公告)日:2011-03-24
    The present invention provides an efficient process for the preparation of hexahydroisoquinolines from dihydroisoquinolines. In particular, the invention provides a good yielding, one-pot process for the synthesis of hexahydroisoquinolines.
    本发明提供了一种从二氢异喹啉制备六氢异喹啉的高效过程。特别地,本发明提供了一种产率高、一锅法合成六氢异喹啉的方法。
  • Process for the Preparation of Hexahydroisoquinolines from 1,2,3,4-Tetrahydroisoquinolines
    申请人:Cantrell Gary L.
    公开号:US20090247756A1
    公开(公告)日:2009-10-01
    The present invention is directed to processes for the synthesis of morphinans. In particular, a process for the asymmetric reduction of an imine moiety in a 3,4-dihydroisoquinoline to produce a tetrahydroisoquinoline, followed by a Birch reduction to produce a hexahydroisoquinoline. In various embodiments, the 3,4-dihydroisoquinoline contains a phenol moiety protected with a labile protecting group. In other embodiments, the imine reduction reaction mixture contains silver tetrafluoroborate.
    本发明涉及吗啡内酯的合成过程。特别是一种过程,用于不对称还原3,4-二氢异喹啉中的亚胺官能团,以产生四氢异喹啉,然后进行Birch还原以产生六氢异喹啉。在各种实施例中,3,4-二氢异喹啉含有一个带有不稳定保护基的官能团。在其他实施例中,亚胺还原反应混合物含有四硼酸
  • Preparation of Hexahydroisoquinolines from Dihydroisoquinolines
    申请人:Cantrell Gary L.
    公开号:US20100022776A1
    公开(公告)日:2010-01-28
    The present invention is directed to processes for the synthesis of morphinans. In particular, a process for the asymmetric reduction of an imine moiety in a 3,4-dihydroisoquinoline to produce a tetrahydroisoquinoline, followed by a Birch reduction to produce a hexahydroisoquinoline. In various embodiments, the 3,4-dihydroisoquinoline contains a phenol moiety protected with a labile protecting group. In other embodiments, the imine reduction reaction mixture contains silver tetrafluoroborate.
    本发明涉及吗啡型物质的合成过程。特别是,本发明提供了一种过程,用于不对称还原3,4-二氢异喹啉中的亚胺官能团,以产生四氢异喹啉,然后进行Birch还原以产生六氢异喹啉。在各种实施例中,3,4-二氢异喹啉包含一个用不稳定保护基保护的官能团。在其他实施例中,亚胺还原反应混合物含有四硼酸
  • A process for the preparation of hexahydroisoquinolines from 1,2,3,4-Tetrahydroisoquinolines
    申请人:Mallinckrodt Inc.
    公开号:EP2149559A1
    公开(公告)日:2010-02-03
    The present invention is directed to processes for the synthesis of morphinans. In particular, a Birch reduction to produce a hexahydroisoquinoline.
    本发明涉及吗啡类化合物的合成工艺。特别是桦木还原法生产六氢异喹啉
查看更多